Becton Dickinson Reports Cybersecurity Vulnerabilities For Alaris Infusion Monitoring Software
Becton Dickinson and Co (NYSE: BDX) issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software.
Alaris Infusion Central, a standalone software — separate from pumps — provides data from the Alaris pumps, which is not sold in the U.S.
It allows healthcare providers to monitor infusion data sent from Alaris Plus and Alaris neXus pumps on a computer.
BD said in the notice that it communicates with customers about cybersecurity vulnerabilities, enabling providers to manage potential risks through awareness and guidance.
The notice relates to the BD Alaris Infusion Central software, versions 1.1 to 1.3.2.
BD said the vulnerability received a 7.3 (High) score in the Common Vulnerability Scoring System (CVSS).
BD said it revised its installation procedure to prevent the vulnerability in future installations. It recommends that users change passwords periodically and ensure physical access controls.
Price Action: BDX shares are up 0.91% at $244.13 on the last check Friday.
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
This article Becton Dickinson Reports Cybersecurity Vulnerabilities For Alaris Infusion Monitoring Software originally appeared on Benzinga.com
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.